The Drk SH3-SH2-SH3 adaptor protein has been genetically identified in a screen for rate-limiting components acting downstream of the Sevenless (Sev) receptor tyrosine kinase in the developing eye of Drosophila. It provides a link between the activated Sev receptor and Sos, a guanine nucleotide release factor that activates Ras1. We have used a combined biochemical and genetic approach to study the interactions between Sev, Drk and Sos. We show that Tyr2546 in the cytoplasmic tail of Sev is required for Drk binding, probably because it provides a recognition site for the Drk SH2 domain. Interestingly, a mutation at this site does not completely block Sev function in vivo. This may suggest that Sev can signal in a Drk-independent, parallel pathway or that Drk can also bind to an intermediate docking protein. Analysis of the Drk-Sos interaction has identified a high affinity binding site for Drk SH3 domains in the Sos tail. We show that the N-terminal Drk SH3 domain is primarily responsible for binding to the tail of Sos in vitro, and for signalling to Ras in vivo.
Introduction
Receptor tyrosine kinases (RTKs) play an important role in mediating the responses of cells to extracellular signals during growth and differentiation of multicellular organisms. Ligand-induced dimerization of receptors leads to the activation of their kinase domain, and subsequent autophosphorylation (Schlessinger and Ullrich, 1992) . The autophosphorylated receptor recruits a number of cytoplasmic proteins which contain a common sequence motif, the SH2 (src-homology 2) domain (Koch et al., 1991; Pawson and Gish, 1992) . SH2 domains bind to specific phosphotyrosine-containing peptide sequences (Songyang et al., 1993; Marengere et al., 1994) and hence may couple the stimulation of RTKs by their ligands to the activation of different cytoplasmic signalling pathways. Biochemical studies in mammalian systems and genetic analysis in Drosophila and Caenorhabditis elegans have indicated that one of these SH2 domain-containing proteins, called Grb2 in mammals (Lowenstein et al., 1992) , Sem-5 in C.elegans (Clark et al., 1992) and Drk in Drosophila (Olivier et al., 1993; Simon et al., 1993) provides a functional link between RTKs and activation of the Ras protein. The Sem-5/Grb2/Drk proteins contain a single SH2 domain flanked by two SH3 (src-homology 3) domains. Binding of these polypeptides to autophosphorylated RTKs is mediated by the SH2 domain (Lowenstein et al., 1992; Olivier et al., 1993) . Grb2 and Drk complex with the Ras guanine nucleotide exchange factor Sos through binding of their SH3 domains -to proline-rich motifs in Sos (Buday and Downward 1993; Egan et al., 1993; Li et al., 1993; Olivier et al., 1993; Rozakis-Adcock et al., 1993; Simon et al., 1993) . Both genetic and biochemical studies have shown that activation of Ras by RTKs stimulates a conserved kinase cascade consisting of Rafl, MAP kinase kinase (MAPKK) and MAP kinase (MAPK) (for a recent review, see Marshall, 1994) .
In Drosophila, mutations in drk impair signalling via the Sevenless (Sev) receptor tyrosine kinase (Simon et al., 1991 (Simon et al., , 1993 Olivier et al., 1993) . The sev gene is expressed in a subset of the 20 cells that give rise to the ommatidial units of the compound eye (Tomlinson et al., 1987) . In the wild type, the initiation of photoreceptor cell development in the R7 precursor cell is dependent on the local activation of Sev by its ligand, the Boss protein, which is expressed on the neighbouring R8 cell (Kramer et al., 1991) . In the absence of a functional Sev or Boss protein, the R7 precursor cell differentiates as a nonneural cone cell (Tomlinson and Ready, 1986; Reinke and Zipursky, 1988) . Conversely, if the Sev RTK is constitutively activated by a mutation and overexpressed in the same subset of cells as the wild-type protein, not only the R7 precursor but also the cone cells initiate neural development (Basler et al., 1991; Dickson et al., 1992) . The precursors of the R7 and the cone cells are often referred to as the R7 equivalence group (Greenwald and Rubin, 1992) . The excess recruitment of R7 cells in sev gain-of-function mutations, or the frequent loss of R7 cells in weak sev mutations, provide genetically sensitized systems that have been used to screen for second-site modifiers (Simon et al., 1991; Olivier et al., 1993; T.R. and E.H., unpublished data) . Loss-of-function mutations of drk are homozygous lethal, but in the heterozygous condition suppress the recruitment of multiple R7 cells in flies with sev gain-of-function mutations. Furthermore, the association of Drk with an activated form of Sev has been demonstrated by both in vitro binding and coimmunoprecipitation experiments. This interaction is blocked by mutations that affect conserved residues of the Drk SH2 domain involved in phosphotyrosine binding (Olivier et al., 1993) .
Here we present the results of a combined biochemical and genetic analysis of the sequences required for the functional interactions between Sev and Drk and between Drk and Sos. The Sev signalling pathway is particularly well suited for this purpose because mutations in sev or in drk can be analysed in vivo. Using a genetically sensitized system, even small changes in the efficiency of signal transduction can be detected. We show that a single tyrosine residue in the C-terminal tail of the Sev protein plays a central role in the binding of Drk (Songyang et al., 1993 . This motif is found only once in the cytoplasmic domain of the Sev protein, suggesting that this site (Y2546ANE in the C-terminal tail of Sev; Basler and Hafen, 1988) (Sprenger and Nuisslein-Volhard, 1992) with the Sev kinase domain results in the strong constitutive activation of the Sev kinase (Dickson et al., 1992) . The transgene contains the sev enhancer and the hsp70 heat-shock promoter. The sev enhancer controls expression of the transgene in the R7 equivalence group and hence permits analysis of the encoded protein in the Sev pathway. The hsp70 heatshock promoter allows the ubiquitous expression of the mutant protein in all cells of the fly providing sufficient material for biochemical analysis. Several independent transgenic lines were produced with this construct (sEtorso4021-sevY2546F). An identical construct with the K2242M mutation in the ATP binding site of the Sev kinase domain was used as a negative control (sE-torso4021-sevK2242M, Dickson et al., 1992) .
To test the ability of the Torso402l_sevY2546F protein to associate with Drk, we heat shocked flies carrying the sEtorso4021_sev, the sE-torso402l-sevY2546F or the sEtorso4021-sev K2242M transgenes for 45 min at 37°C to induce ubiquitous expression of the transgenes and allowed the flies to recover at room temperature for 3 h. Protein extracts of these flies were then incubated with either antiSev or anti-Drk antisera, and the chimeric Sev proteins were identified in the anti-Sev and anti-Drk immunoprecipitates by immunoblotting with anti-Sev or anti-phosphotyrosine antibodies. Upon heat induction, all three Torso4021-sev with an IC50 of -500 nM ( Figure ID) . In contrast, a phosphopeptide (SSNpYMAPYDNY), corresponding to the Tyr771 autophosphorylation site on the P receptor for platelet-derived growth factor, at a concentration of 20 ,uM had no effect on the association of GSTDrk with the activated Sev receptor. These results are consistent with a model in which the association of Sev with Drk is dependent on receptor autophosphorylation, primarily at Tyr2546.
A mutation in Tyr2546 of Sev reduces but does not eliminate Sev function in vivo Given the dramatic effect of the Y2546F mutation on Drk binding in vitro, we wanted to know whether this mutation interferes with signalling from the Sev receptor in vivo. Previously it was shown that the constitutive activation of the Sev receptor under the control of the sev enhancer results in the recruitment of additional R7 cells (Basler et al., 1991; Dickson et al., 1992) . The number of additional R7 cells is a sensitive measure for the signalling efficiency from the receptor. Flies that lack endogenous sev gene function due to the sevd2 null allele but carry one copy of the sE-torso4021-sev transgene have rough eyes with multiple R7 cells per ommatidium (compare Figure 2A , D and B, E) . Flies carrying one copy of the mutant sE-torso4021-sev Y2546F construct possess smooth eyes ( Figure 2C, F) . To quantify the extent of the suppression caused by the Y2546F mutation, we counted the number of R7 photoreceptor cells per ommatidium in several independent transformant lines of the sE-torso4021-sev and the sE-torso4021-sev Y2546F construct. Compared with the transformants carrying the sE-torso4021-sev transgene, which on average possess 3.8 + 1.0 (n= 128) R7 cells per ommatidium, the number of R7 cells is reduced to an average of 0.3 + 0.3 (n=241) R7 cells per ommatidium in the three sE-torso402' sev Y2546F transformants lines analysed. Interestingly, the sev 2, sEtorso4021_sevY2546F flies still contain some ommatidia with one R7 cell ( Figure 2F ). Furthermore, flies carrying two copies of the sE-torso4021-sevY2546F construct possess rough eyes containing ommatidia with multiple R7 cells similar to flies carrying a single copy of the unmutated sE-torso4021-sev transgene (data not shown). This indicates that the Torso402l_sevY2546F protein still retains residual activity despite the lack of the putative Drk binding site.
Since the rough eye phenotype of sE-torso4021-sev is caused by the transformation of the cone cell precursors into R7 cells and not by the recruitment of the R7 precursor itself, we wanted to test whether the same mutation also prevents the specification of the R7 cell proper. To test the effect of the Y2546F mutation in a sensitized system for the R7 cell, we introduced the Y2546F mutation into a transgene that encodes a partially functional Sev protein carrying a mutation in the extracellular domain (sE-sev351, B.D. and E.H., unpublished). In a sev mutant background, flies homozygous for the transgene possess on average 0.81 + 0.06 (n=354) R7 cells per ommatidium. In contrast, in flies carrying the identical construct with the Y2546F mutation, the number of R7 cells is reduced to 0.03 + 0.04 (n=365). Therefore, this mutation reduces the efficiency of signalling from Sev in all cells that can adopt an R7 cell fate.
The N-terminal SH3 domain of Drk is required for binding to the proline-rich C-terminus of Sos Drk has been previously shown to associate in vitro with the C-terminal proline-rich tail of Sos (Olivier et al., 1993; Simon et al., 1993) , and similar results have been obtained for the mammalian proteins Grb2 and mSos 1 (Egan et al., 1993; Li et al., 1993 , Rozakis-Adcock et al., 1993 Sos tail, whereas W189A was reduced in its Sos binding (data not shown). These results suggest that the more N-terminal of the two Drk SH3 domains is primarily responsible for the association of Drk with Sos.
We wanted to exclude the possibility that the observed binding of the mutant Drk proteins was in part due to residual activity of the SH3 domain carrying the Tmp to Ala mutation. We therefore constructed two mutant Drk proteins that entirely lack either the N-terminal SH3 domain [SH2-SH3(C)I or the C-terminal SH3 domain [SH3(N)-SH2I. These truncated Drk proteins were produced in bacteria and analysed for their ability to bind the Sos tail in a filter binding assay. Immobilized GST protein alone was unable to bind to the wild-type Drk protein ( Figure 3B , lane 1). The mutant Drk protein lacking the C-terminal SH3 domain bound in vitro to the Sos tail with an efficiency approaching that of full-length wild-type Drk protein ( Figure 3B , lanes 2 and 3). In contrast, the mutant Drk protein lacking the N-terminal SH3 domain bound only very weakly to the Sos tail ( Figure 3B , lane 4). These results suggest that the Nterminal SH3 domain is both necessary and sufficient for efficient association with Sos in vitro. protein even 16 h after the induction by heat shock (data not shown).
To assay the function of the DrkW36A and DrkWl89A mutant proteins in the Sev pathway, we tested their ability to substitute for the function of the wild-type Drk protein in a sE-torso4021-sev; drkRII+ background. The results of this analysis are shown in Figure 5 and their quantification is shown in Figure 5G . We have previously shown that the removal of one copy of the endogenous drk gene suppresses the rough eye phenotype caused by a constitutively activated Sev RTK (Olivier et al., 1993) . In sEtorso4021-sev flies, 99% of the ommatidia contain multiple R7 cells ( Figure SA) . Removal of one copy of drk reduces the fraction of ommatidia with multiple R7 cells to 33%
(sE-torso4021-sev; drkRl/+, Figure SB) . Expression of the wild-type drk transgene in sE-torso4021-sev; drkRl/+; sEdrk flies fully complements the suppression caused by the drkRl mutation and restores this value to 95% ( Figure 5C ). In contrast, only 22% of the ommatidia possess multiple R7 cells in flies carrying the transgene that encodes a Drk Fig. 4 . Expression of drk under the control of the hsp7O promoter. Third instar larvae of the following genotype were subjected to a I h heat shock at 37°C: w118 (1) protein with a mutant N-terminal SH3 domain ( Figure  5D ). This suggests that this protein is unable to provide normal Drk function. However, 78% of all ommatidia in sE-torso4021-sev; drkRl/+ flies carrying the sE-DrkWJ89A construct have more than one R7 cell ( Figure SE) , suggesting the mutation in the C-terminal SH3 domain has comparatively little effect on Drk function in the Sev pathway. These results reflect the in vitro binding properties. Since even a Drk protein lacking the C-terminal SH3 domain was able to bind to the Sos tail we wanted to verify that this protein was functional in vivo. In flies carrying the sE-drkSH3(N)-SH2 transgene, 76% of the ommatidia contain multiple R7 cells ( Figure SF) . Therefore it appears that Drk can function in the Sev pathway even in the complete absence of its C-terminal SH3 domain. Drk is also required in other developmental pathways (Simon et al., 1991; Doyle and Bishop, 1993; DiazBenjumea and Hafen, 1994) . The recessive lethality associated with drk mutations is fully rescued by the repeated ubiquitous induction of a wild-type drk cDNA under the control of the hsp7O promoter (Olivier et al., 1993) . In contrast, neither the drkW36A nor the drkSH3(N)-SH2 were able to rescue drk mutant flies. Only the drkWI89A construct partially rescued drk homozygous mutant flies (20% of the rescue ability of the wild-type drk transgene). As in signalling downstream of the Sev RTK, the Nterminal SH3 domain appears to be essential for Drk function in other pathways. However, the fact that the Drk protein lacking the C-terminal SH3 domain was unable to rescue the lethality suggests that the C-terminal SH3 domain has a more important function in these other signalling pathways.
Drk binds to two proline-rich motifs in the C-terminal tail of Sos
The C-terminal region of Sos contains three central prolinerich motifs designated P1, P2 and P3, that might represent SH3 binding sites (see Figure 6A) . To test for a direct interaction of Drk with these regions of Sos, GST fusion proteins containing one or more of these proline-rich GST-Sos fusion proteins containing multiple proline-rich sequences appeared to bind more Drk than fusions with individual proline-rich motifs. This is illustrated in Figure  6 , where concentrations of purified Drk ranging from 50 to 1250 nM were tested for binding to -300 nM of GSTSos Pl-P3 fusion protein ( Figure 6B ). This is compared with the result obtained using 300 nM of a fusion protein containing a single motif, GST-Sos P3 ( Figure 6C ), and to GST alone. Optical densitometry of the Coomassie Blue-stained Drk band revealed that almost four times more Drk was bound to the construct containing multiple proline-rich motifs ( Figure 6D ).
To further delineate the likely contact points on Sos for the Drk SH3 domain, synthetic peptides corresponding to three proline-rich motifs within the region of Sos shown to interact directly with Drk were synthesized, and employed in competition experiments. In these studies, the peptides, at concentrations from 70 to 700 nM, were incubated in a solution containing 600 nM Drk and 300 nM GST-Sos P1-P3 fusion protein for 90 min at 4°C. Following this period, excess GST beads were added and the mixture allowed to incubate for a further 30 min After washing, the beads were analysed for the amount of Drk present and compared with a control where no peptide was added. As shown in Figure 7A , two of the peptides displayed inhibitory properties. Peptide P1, sequence YRAVPPPLPPRR, showed the strongest inhibition, IC50=50 ,uM; while P2, sequence GELSPPPIPPRL, was poorer, IC50 = 280,M ( Figure 7B ). The third peptide, P3, sequence GAPDAPTLPPRD, showed little inhibition.
Taken together, these results indicate that the N-terminal Drk SH3 domain is principally responsible for the binding of Drk to Sos. Furthermore, analysis of potential SH3 binding sites has defined specific proline-rich motifs in the Sos tail that can associate with Drk in vitro. The highest affinity site is represented by the peptide YRAVPPPLPPRR. However, Sos polypeptides containing multiple proline-rich motifs apparently bound Drk more efficiently than proteins with single proline-rich motifs. (Songyang et al., 1993 (Pelicci et al., 1992; RozakisAdcock et al., 1992; Baltensperger et al., 1993; Feng et al., 1993; Pronk et al., 1993; Skolnik et al., 1993a,b; Vogel et al., 1993 , Li et al., 1994 . While both Shc and Syp have SH2 domains, Shc can also bind to activated receptors in an SH2 domain-independent way through its PTB domain (Blaikie et al., 1994; Kavanaugh and Williams, 1994 (Bennett et al., 1994) , is perfectly conserved in Csw. There is, however, no direct evidence yet that Csw interacts with, or is a substrate for, the Sev receptor.
Evidence of the third possibility that RTK signalling occurs via a parallel Drk-independent parallel pathway, has also been obtained from vertebrates. It has been shown that activated RTKs can associate with and phosphorylate a number of SH2 domain-containing proteins, several of which can potentially activate the Ras pathway (Koch et al. 1991; Pawson and Schlessinger, 1993; Valius and Kazlauskas, 1993) . For the colony-stimulating factor 1 (CSF-1) receptor it has been shown that only the combined mutation of Grb2 and phosphoinositol-3 (PI-3) kinase binding sites completely abrogates signal transduction, whereas mutation of either binding site alone reduced the ability to change morphology or growth rate in response to CSF-1 stimulation (van der Geer and Hunter, 1993). So far, there is no evidence for an involvement of PI-3 kinase in Sev-mediated signal transduction in Drosophila. The existence of a Drk-independent pathway is suggested, however, by the analysis of drk homozygous mutant cell clones in the eye or in the adult cuticle. The phenotypes of the strongest Drk alleles are less severe than those observed in clones of other mutations in the pathway, such as Raf, Rasl or the corresponding receptors (Simon et al., 1991; Diaz-Benjumea and Hafen, 1994) . Although a residual Drk function in the alleles tested could explain the different strength in phenotypes, we think this is unlikely since both alleles tested result in the substitution of conserved amino acids in the SH2 domain which completely abolish SH2 binding in vitro (Olivier et al., 1993) . Furthermore, the Drk alleles tested exhibit the same degree of suppression of sE-torso 4021-sev as the drk null allele, drkAP24. We therefore consider it quite likely that a parallel, Drk-independent pathway leading to the activation (Koyama et al., 1993) . Furthermore, a truncated Drk protein that completely lacks the C-terminal SH3 domain is still able to bind to Sos, albeit with reduced efficiency. The results obtained in vitro correlate well with the results of our in vivo analysis of the Drk SH3 domains.
Constructs encoding either the DrkwI89A protein or a Drk protein completely lacking the C-terminal SH3 domain were able to largely rescue the dominant suppression of the rough eye phenotype of sE-torso4021-sev by drk null mutations. However, Drk with the substitution of the analogous residue in the N-terminal SH3 domain failed to bind efficiently to the Sos tail and was unable to rescue the suppression by drk of sE-torso4021-sev. Therefore, the N-terminal SH3 domain is necessary and sufficient for efficient binding of Drk to Sos in vitro, and for efficient signal transduction from the Sev kinase in vivo.
Recent structural analysis has shown that the N-and C-terminal SH3 domains of Sem-5 and Grb2 bind to proline-rich peptides in the opposite orientation (i.e. Cto N-terminal) compared with previously observed SH3 complexes (Feng et al., 1994; Lim et al., 1994; Wittekind et al., 1994) These Sem-5/Grb2 binding peptides contain the sequence NH2 X-P-p-X-P-p-R COOH where X is an aliphatic residue, p is a scaffolding residue (often a proline) that maintains the polyproline type II helix, and the Cterminal arginine forms a salt bridge with an acidic SH3 domain residue. Additional C-terminal arginines appear to increase the binding affinity (Feng et al., 1994) . The high affinity binding site for Drk on Drosophila Sos, represented by the P1 peptide YRAVPPPLPPRR, conforms to this consensus. The aliphatic-proline pairs (P-P; L-P) probably fit into the hydrophobic binding pockets on the Drk N-terminal SH3 domain, while the underlined arginine potentially makes a salt bridge with Glu16 (Lim et al., 1994; Wittekind et al., 1994) . Our data suggest that the N-terminal Drk SH3 domain is primarily responsible for binding to Sos, and may contact the YRAVPPPLPPRR (P1) site in the Sos tail.
The in vitro binding studies suggest that the C-terminal SH3 domain enhances the binding of the N-terminal SH3 domain to Sos. The wild-type form of Drk binds more strongly to the Sos tail than either DrkwI19A or the Cterminally truncated Drk. Similarly, the drk transgenes with a mutation or a deletion in the C-terminal SH3 domain are somewhat less efficient in rescuing the drk function than the wild-type gene. It is therefore likely that the C-terminal SH3 domain of Drk strengthens the DrkSos interaction by interacting with a second proline-rich sequence, such as the P2 sequence, upon binding of the N-terminal SH3 domain to the PI sequence. The Cterminal Drk SH3 domain might also play a role distinct from binding to Sos. It has also been shown that both SH3 domains of Grb2 interact with Dynamin, a GTPase that functions in endocytosis and synaptic transmission (Gout et al., 1993; Scaife et al., 1994) . The C-terminal SH3 domain may similarly be involved in coupling Drk to other proteins that do not play a major role in Sev signalling. A more central role of the C-terminal SH3 domain of Drk in other signalling pathways is suggested by our observation that the Drk construct lacking the Cterminal SH3 domain was unable to rescue the lethality associated with drk mutations, whereas the same construct functioned to near normal levels in the Sev pathway.
Finally, this paper illustrates the importance of utilizing both in vitro assays and a sensitive in vivo analysis to decipher the functional importance of the individual domains of Drk. By applying both of these approaches we were able to identify a site in Sev required for association with Drk, to define contact sites between the Drk SH3 domains and Sos and to test the importance of these interactions in vivo.
Materials and methods

Genetics
Mutations in the drk gene were isolated in a genetic screen for secondsite modifiers of the rough eye phenotype of the gain-of-function mutation SevS11 which encodes a constitutively activated Sev protein (Basler et al., 1991; Olivier et al., 1993; T.R. and E.H., unpublished data) . All experiments were performed in a sev1'2 null mutant background (Basler et al., 1991) . Loss-of-function mutations in the drk gene lacking detectable levels of Drk protein were generated by mobilizing the Pelement insertion drkP24 using a stable source of transposase (Robertson et al., 1988) . Based on the suppression of the torso4021-sev rough eye phenotype, non-complementation of existing drk alleles and the absence of Drk protein on Western blots (see Results), drkAP24 was designated as a complete loss-of-function mutation. For the experiments described in Figure 5 , transgenic lines carrying the different drk constructs were crossed to it, 8, sev12 flies bearing the drkRl mutation and the sEtorso 402l_sev transgene on the same chromosome. To test whether ubiquitous expression of the drk constructs could rescue the lethality of drk mutations, we crossed drYAP24/Bc Gla flies with dr5AP24/Bc Gla flies homozygous for the sE-drk"'I, sE-drkU-16A or sE-drkVIW89A, respectively.
The temperature was shifted to 37°C for 60 min every 8 h throughout development. These mutant constructs behaved identically in independent rescue experiments with drkRlIdrkE(se'v2B flies (data not shown). The rescue ability of the drkSH3(N)-SH2 construct lacking the C-terminal SH3 domain was tested in a cross of drkR /Sco flies with drkEev)2B/CvO; drkSH3(N)-SH2/+ using the same temperature treatment. Whereas the expected number of drkRl/drkE(ev2B; .sE-drk-'±+ flies were obtained in the control experiment (79/305 flies carrying the sE-drkVi' construct), no drkRl/drk'E(se)2B; sE-drkSH3(,V)SH2/+ flies survived (0/10)7).
Plasmid construction for germline transformations The torso402_-sev and torso4021_sev,K2242M constructs are described in Dickson et al. (1992) . The Y2546F substitution was introduced into torso4021-sev by replacing a 1.1 kb BamHI cDNA fragment with the corresponding fragment from a set cDNA in which the Y2546 codon has been mutated by site-directed mutagenesis. The hypomorphic set construct, .sei-31, in which the codons for Y1485 and W1486 in the extracellular domain of Sev have both been replaced by alanine codons, was generated in the course of a structure-function analysis of the Sev extracellular domain (B.D. and E.H., unpublished data). The W36A and W189A Drk mutations were generated by site-directed mutagenesis of the drk cDNA using the oligonucleotides GGAAGACGATFCAAATGC-ATATCGCGCGGAGC and GCTCCGATGAGAACGCGTGGAACGG-CGAG, respectively. For germline transformations a modified pW8 transformation vector was used (Klemenz et al., 1987) . All derivatives of the original torso4021-sev! and drk constructs are under the control of a single copy of the 1.2 set enhancer fragment and the hsp70 promoter (sE). Expression of the partially functional sei-VS and sel351-Y2546F receptors is driven by a duplicated sev enhancer (Basler et al., 1991) .
Transgenic lines were generated by injection of Quiagen purified plasmid DNA into wu/ 58sev'12 or IIM8 embryos as described previously (Basler et al., 1991) . For all constructs, several independent transformant lines were established.
Scanning electron microscopy and histology Adult flies for scanning microscopy were stored in 70% acetone before they were critical-point dried and coated for examination with a Hitachi S-4000 scanning electron microscope. The preparation of histological sections has been described previously (Basler and Hafen, 1988) .
Western blotting and immunoprecipitation
For immunoprecipitations, adult flies were homogenized in PLC-LB [50 mM HEPES (pH 7.5), 150 mM sodium chloride, 10% glycerol, 1% Triton X-100, 1.5 mM MgClI I mM EGTA, 100 mM NaF and 10 mM NaPPi] containing 1 mM sodium orthovanadate and I mM phenylmethylsulphonyl fluoride. Lysates were clarified by centrifugation and incubated with 2 ,ug/ml affinity-purified anti-Drk or 1:200 dilution of anti-Sev, and protein A-Sepharose, for 90 min at 4°C. Immunoprecipitates were washed three times with I ml HNTG [20 mM HEPES (pH 7.5), 150 mM sodium chloride, 10% glycerol, 0.1I% Triton X-100 and 1 mM sodium orthovanadatel, and then boiled for 5 min in SDS sample buffer. All samples were fractionated by electrophoresis on 8.25%, or 10% SDSpolyacrylamide gels, and transferred to nitrocellulose in a semi-dry blotting apparatus at 0.8 mA/cm2 for I h. Filters were blocked for I h at room temperature in 5% non-fat dry milk in TBS-T [20 mM Tris (pH 7.5), 150 mM sodium chloride, and 0.05% Triton X-I001 and probed with 2 jtg/ml affinity-purified anti-Drk, or 1:1000 dilution of anti-Sev.
The anti-Drk antiserum was generated in a rabbit against a non-GSTDrk fusion protein (Olivier et al., 1993) . The anti-Sev antiserum (G24) was generated in a goat against a bacterially synthesized protein corresponding to cytoplasmic kinase domains of Sev. For anti-phosphotyrosine immunoblots, filters were blocked in 5% bovine serum albumin (BSA), 1% ovalbumin in TBS-T and probed with I ,ug/ml affinitypurified anti-phosphotyrosine antibodies as described previously (Letwin et al., 1988) . Anti-Drk and anti-Sev immunoblots were developed using either the ECL kit (Amersham), or [12511protein A (Amersham). The anti-phosphotyrosine immunoblots were processed using l125lJprotein A.
GST fusion proteins
Drk was amplified by polymerase chain reaction (PCR) and subcloned into the bacterial expression plasmid pGEX-KT (Pharmacia) as described previously (Olivier et al. 1993 ). The drkW36A and drk""'89A mutants were produced by PCR and subcloned into pGEX-KT. The deletion mutants of Drk, SH3(N)-SH2 (amino acids 1-156) and SH2-SH3(C) (amino acids 60-211) were amplified by PCR and subcloned into pGEX-KT. Four regions of Sos were amplified by PCR and subcloned into the pGEX-KT vector; pGEX Sos-N encodes amino acids 505-692, pGEX Sos-tail amino acids 1225-1405, pGEX Sos Pl-P3 amino acids 1313-1387, and pGEX Sos P3 amino acids 1353-1387. All plasmid constructs were sequenced using the Sequenase method (United States Biochemical Corporation) and transformed into Escherichia coli DHS5X. Bacteria were grown to an OD600 of 0.6 and fusion proteins were induced at 30°C with I mM isopropyl-f-D-thiogalactosidase (IPTG) for 3 h. Cells were collected, sonicated in PBS-T2 (PBS, 1% Triton X-100 and 1% Tween) and clarified by centrifugation. The supernatant was incubated with glutathione-agarose beads for I h at 4°C and washed three times with PBS-T'.
In vitro binding studies Adult flies were lysed in PLC lysis buffer at 10 flies per ml of buffer, the homogenate was cleared by centrifugation and incubated with immobilized GST or GST fusion proteins (2.5 ,ug) for 90 min at 4°C. All complexes were washed three times with HNTG, boiled for 5 min in SDS sample buffer, resolved by SDS-PAGE (8.25%) and transferred to nitrocellulose. Filters were blocked and probed with anti-phosphotyrosine antibodies as described above. Protein complexes were also subjected to in vitro kinase assays. Both immune complexes and GST fusion protein complexes were incubated with 0.5 jCi of [,y-32P]ATP in KRB 120 mM HEPES (pH 7.4), 25 mM magnesium chloride, 4 mM manganous chloride and 0.1 mM sodium orthovanadate] at room temperature for 15 min. Reactions were stopped by adding an equal volume of 2X SDS sample buffer. A fraction of the kinase reaction was separated by SDS-PAGE and the gel was fixed, dried and exposed to film.
GST-SosN and GST-Sos tail fusion proteins were expressed in bacteria and purified with glutathione-agarose beads. Immobilized GSTSosN and GST-Sos tail were mixed with I gg, 0.5 gg or 0.25 .tg of purified wild-type Drk, DrkW36A or DrkwI89A and incubated for 90 min at 4°C. Complexes were washed three times with HNTG, boiled for 5 min in SDS sample buffer, resolved by SDS-PAGE (10%) and transferred to nitrocellulose. Filters were blocked and immunoblotted with anti-Drk antibodies and processed using [1251] protein A. The amount of Drk was quantified using a Phosphorlmager (Molecular Dynamics).
Purified GST, GST-SosN and GST-Sos tail bacterial fusion proteins, I ,ug of each, were resolved by 10% SDS-PAGE and were transferred to nitrocellulose. Filters were blocked in TBS containing 5% BSA, 1% ovalbumin and 0.1% SDS overnight at 4°C. These filters were probed using purified wild-type or mutant Drk protein from bacteria for 3 h at room temperature at I sg/ml and washed three times with TBS + 0. I% SDS. Complexes were detected by immunoblotting using affinity-purified anti-Drk antibodies in 5% BSA, 1% ovalbumin in TBS and processed with [ 12511protein A.
To determine the concentration dependence of Drk binding to truncated GST-Sos fusion proteins, purified Drk protein, at concentrations of 0, 50, 100, 200, 300, 400, 500, 600, 750, 1000 and 1250 ,uM, was incubated with a volume of bacterial lysate containing -300 nM of GST-Sos P1-P3, GST-Sos P3, or GST in I ml PLC lysis buffer for 2 h at 4°C. Forty ,ul of 50% (v/v) glutathione-agarose beads were added and the incubation continued for 20 min. Following three 1 ml PLC lysis buffer washes of the beads, bound proteins were resolved by 15% SDS-PAGE and detected by Coomassie Blue staining.
Peptide competition
The phosphopeptide pY2546 (KQLpYANEGVSR) was added to lysates containing Torso-sev, to final concentrations of 20, 10, 1, 0.5, 0.2 and 0.1 ,uM in the presence of 2.5 ,ug immobilized GST-Drk fusion protein and incubated for 90 min at 4°C. As a control, non-specific phosphopeptide pY771 (SSNpYMAPYDNY) was also used at 20 tM. All complexes were washed three times with HNTG, boiled for 5 min in SDS sample buffer, resolved by SDS-PAGE (8.25%) and transferred to nitrocellulose. Filters were blocked and probed with anti-phosphotyrosine antibodies as described above and quantified using a Phosphorlmager (Molecular Dynamics).
Peptide competition of Drk binding to truncted GST-Sos Pl-P3 fusion proteins Approximately 600 nM of purified Drk protein was incubated with bacterial lysates containing 300 nM GST-Sos PI-P3 fusion protein in the presence of proline-rich peptides P1 (YRAVPPPLPPRR), P2 (GELSPPPIPPRL) and P3 (GAPDAPTLPPRD), at concentrations ranging from 70 to 700 gM (see Figure 7) . Following a 90 min incubation period at 4°C, 40 ml of 50% (v/v) glutathione-agarose beads was added and the incubation continued for a further 30 min. The beads were washed with three 1 ml volumes of PLC lysis buffer, bound proteins resolved by 15% SDS-PAGE and detected by Coomassie Blue staining. The magnitude of peptide inhibition, monitored relative to a control with no peptide added, was determined from the intensity of the Drk band estimated by optical densitometry, plotted in a graph as a function of peptide concentration.
